The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
A compelling body of non-randomized evidence has established stereotactic ablative lung radiotherapy (SABR) as a standard of care for medically inoperable patients with peripheral early-stage non-small cell lung cancer (NSCLC). This convenient outpatient therapy, which is typically delivered in 3-8...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Cancer Association
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138920/ |